Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CARsgen Therapeutics Announces 2025 Interim Results 2025-08-15 08:15
BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan 2025-08-13 20:00
Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform 2025-08-13 15:36
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model 2025-08-13 07:00
Mabwell Announces First Patient Dosed in the US Clinical Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated with ADCs 2025-08-12 22:00
Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million 2025-08-12 09:36
AGEBOX Presents iKids-Growth: Pioneering Safe and Natural Support for Children's Height Development 2025-08-11 21:30
AMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs 2025-08-11 20:00
Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy 2025-08-11 10:52
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System 2025-08-09 09:30
GenScript Unveils New Global Identity: "Scripting Possibilities" to Power the Future of Biotechnology 2025-08-08 20:30
WuXi XDC Included in MSCI China All Share Index 2025-08-08 17:32
Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing to Advance Late-Stage Pipeline and Global Expansion 2025-08-07 18:00
US NCI Sponsors Senhwa Biosciences' Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma 2025-08-07 14:35
FDA approves expanded indication for AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in cytokine release syndrome (CRS) 2025-08-06 20:00
The U.S. FDA Granted Fast Track Designation to Dizal's Birelentinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma 2025-08-06 19:02
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year 2025-08-06 08:00
Sanyou Bio Wins the "2025 Best Customer Satisfaction CRO Award" 2025-08-05 22:00
Court Sides with Cardiovalve in Edwards patent spat 2025-08-05 20:00
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application 2025-08-05 20:00
1 12 13 14 15 16 261